@article{3139257,
    title = "The Mount Sinai experience with orthotopic liver transplantation for
benign tumors: Brief report and literature review: Case reports",
    author = "Schwartz, M. E. and Roayaie, S. and Konstadoulakis, M. M. and Gomatos, and I. P. and Miller, C. M.",
    journal = "Transplantation Proceedings",
    year = "2008",
    volume = "40",
    number = "5",
    pages = "1759-1762",
    publisher = "EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC",
    issn = "0041-1345",
    doi = "10.1016/j.transproceed.2008.02.076",
    abstract = "Orthotopic liver transplantation (OLT) is performed for benign hepatic
lesions that are symptomatic, too large to be resected, have a malignant
transformation potential, cause debilitating/life-threatening
manifestations, or in patients experiencing posthepatectomy acute liver
failure. Among benign tumors, polycystic liver disease (PLD) is the most
common indication for OLT alone, or combined liver-kidney
transplantation. Our 10-year experience with OLT for benign tumors
includes two patients with PLD and one with a benign giant fibrous
tumor. In this report, we present our experience with OLT for benign
liver tumors, commenting on relevant published studies."
}